Retinal Disorders Treatment Market by Type and Distribution Channel- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 176 Category: Pharma & Healthcare Report Code : HC0115203
Retinal Disorders Treatment Market By Type (Macular Degeneration, Diabetic Retinopathy, Others) and Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Retinal Disorders Treatment Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Retina is like a film of the camera which sends the image to the brain for processing and a damaged retina can lead to significant visual disturbances many of which may become permanent if not treated in time. There are different types of retinal diseases. Some affect only the macula, such as macular pucker (epiretinal membrane), age-related macular degeneration, or macular hole.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Retinal Disorders Treatment Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Santen Pharmaceutical Co. Ltd.
- REGENERON
- Graybug Vision Inc.
- Shire (Takeda Pharmaceuticals)
- Bayer AG
- Genentech Inc.
- Acucela Inc.
- Pfizer Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Retinal Disorders Treatment Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Macular Degeneration
o Diabetic Retinopathy
o Others
· Retinal Disorders Treatment Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospital Pharmacy
o Online Pharmacy
o Retail Pharmacy
· Retinal Disorders Treatment Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Santen Pharmaceutical Co. Ltd.
o REGENERON
o Graybug Vision Inc.
o Shire (Takeda Pharmaceuticals)
o Bayer AG
o Genentech Inc.
o Acucela Inc.
o Pfizer Inc.
· Retinal Disorders Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Retinal Disorders Treatment Market, By Country
o U.S. Retinal Disorders Treatment Market
o Canada Retinal Disorders Treatment Market
o Mexico Retinal Disorders Treatment Market
o Europe
§ Europe Retinal Disorders Treatment Market, By Country
o UK Retinal Disorders Treatment Market
o Germany Retinal Disorders Treatment Market
o France Retinal Disorders Treatment Market
o Russia Retinal Disorders Treatment Market
o Italy Retinal Disorders Treatment Market
o Rest of Europe Retinal Disorders Treatment Market
o Asia-Pacific
§ Asia-Pacific Retinal Disorders Treatment Market, By Country
o China Retinal Disorders Treatment Market
o Japan Retinal Disorders Treatment Market
o South Korea Retinal Disorders Treatment Market
o India Retinal Disorders Treatment Market
o Southeast Asia Retinal Disorders Treatment Market
o Rest of Asia-Pacific Retinal Disorders Treatment Market
o South America
§ South America Retinal Disorders Treatment Market
o Brazil Retinal Disorders Treatment Market
o Argentina Retinal Disorders Treatment Market
o Columbia Retinal Disorders Treatment Market
o Rest of South America Retinal Disorders Treatment Market
o Middle East and Africa
§ Middle East and Africa Retinal Disorders Treatment Market
o Saudi Arabia Retinal Disorders Treatment Market
o UAE Retinal Disorders Treatment Market
o Egypt Retinal Disorders Treatment Market
o Nigeria Retinal Disorders Treatment Market
o South Africa Retinal Disorders Treatment Market
o TurkeyRetinal Disorders Treatment Market
o Rest of MEA Retinal Disorders Treatment Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Retinal Disorders Treatment Market, By Type
5.1. Introduction
5.2. Global Retinal Disorders Treatment Revenue and Market Share by Type (2017-2021)
5.2.1. Global Retinal Disorders Treatment Revenue and Revenue Share by Type (2017-2021)
5.3. Macular Degeneration
5.3.1. Global Macular Degeneration Revenue and Growth Rate (2017-2021)
5.4. Diabetic Retinopathy
5.4.1. Global Diabetic Retinopathy Revenue and Growth Rate (2017-2021)
5.5. Others
5.5.1. Global Others Revenue and Growth Rate (2017-2021)
6. Retinal Disorders Treatment Market, By Applications
6.1. Introduction
6.2. Global Retinal Disorders Treatment Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Retinal Disorders Treatment Revenue and Revenue Share by Applications (2017-2021)
6.3. Hospital Pharmacy
6.3.1. Global Hospital Pharmacy Revenue and Growth Rate (2017-2021)
6.4. Online Pharmacy
6.4.1. Global Online Pharmacy Revenue and Growth Rate (2017-2021)
6.5. Retail Pharmacy
6.5.1. Global Retail Pharmacy Revenue and Growth Rate (2017-2021)
7. Retinal Disorders Treatment Market, By Region
7.1. Introduction
7.2. Global Retinal Disorders Treatment Revenue and Market Share by Regions
7.2.1. Global Retinal Disorders Treatment Revenue by Regions (2017-2021)
7.3. North America Retinal Disorders Treatment by Countries
7.3.1. North America Retinal Disorders Treatment Revenue and Growth Rate (2017-2021)
7.3.2. North America Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Retinal Disorders Treatment by Countries
7.4.1. Europe Retinal Disorders Treatment Revenue and Growth Rate (2017-2021)
7.4.2. Europe Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Retinal Disorders Treatment by Countries
7.5.1. Asia-Pacific Retinal Disorders Treatment Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Retinal Disorders Treatment by Countries
7.6.1. South America Retinal Disorders Treatment Revenue and Growth Rate (2017-2021)
7.6.2. South America Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Retinal Disorders Treatment by Countries
7.7.1. Middle East and Africa Retinal Disorders Treatment Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Santen Pharmaceutical Co. Ltd.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. REGENERON
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Graybug Vision Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Shire (Takeda Pharmaceuticals)
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bayer AG
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Genentech Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Acucela Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Pfizer Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Retinal Disorders Treatment Market Forecast (2022-2027)
9.1. Global Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Retinal Disorders Treatment Market Forecast by Regions (2022-2027)
9.2.1. North America Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.1.1. United States Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.1.2. Canada Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.1.3. Mexico Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.2. Europe Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.2.1. Germany Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.2.2. France Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.2.3. UK Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.2.4. Russia Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.2.5. Italy Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.3. Asia-Pacific Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.3.1. China Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.3.2. Japan Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.3.3. Korea Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.3.4. India Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.4. South America Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.4.1. Brazil Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.4.2. Argentina Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.4.3. Columbia Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.4.4. Rest of South America Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.5. Middle East and Africa Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.5.3. Egypt Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.5.4. Nigeria Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.5.5. South Africa Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.5.6. Turkey Retinal Disorders Treatment Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Retinal Disorders Treatment Market Forecast (2022-2027)
9.3. Retinal Disorders Treatment Market Forecast by Type (2022-2027)
9.3.1. Retinal Disorders Treatment Forecast by Type (2022-2027)
9.3.2. Retinal Disorders Treatment Market Share Forecast by Type (2022-2027)
9.4. Retinal Disorders Treatment Market Forecast by Applications (2022-2027)
9.4.1. Retinal Disorders Treatment Forecast by Applications (2022-2027)
9.4.2. Retinal Disorders Treatment Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Retinal Disorders Treatment Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Retinal Disorders Treatment Revenue and Revenue Share by Type (2017-2019)
Figure Global Macular Degeneration Revenue and Growth Rate (2017-2019)
Figure Global Diabetic Retinopathy Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Retinal Disorders Treatment Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospital Pharmacy Revenue and Growth Rate (2017-2019)
Figure Global Online Pharmacy Revenue and Growth Rate (2017-2019)
Figure Global Retail Pharmacy Revenue and Growth Rate (2017-2019)
Table Global Retinal Disorders Treatment Revenue by Regions (2017-2019)
Figure North America Retinal Disorders Treatment Growth Rate (2017-2019)
Figure North America Retinal Disorders Treatment Revenue and Growth Rate (2017-2019)
Figure North America Retinal Disorders Treatment by Countries (2017-2019)
Figure North America Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2019)
Figure United States Retinal Disorders Treatment Growth Rate (2017-2019)
Figure United States Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Canada Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Mexico Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Europe Retinal Disorders Treatment Revenue and Growth Rate (2017-2019)
Figure Europe Retinal Disorders Treatment by Countries (2017-2019)
Figure Europe Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Germany Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Germany Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Retinal Disorders Treatment Growth Rate (2017-2019)
Figure France Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Retinal Disorders Treatment Growth Rate (2017-2019)
Figure UK Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Russia Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Italy Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Rest of Europe Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Asia-Pacific Retinal Disorders Treatment Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Retinal Disorders Treatment by Countries (2017-2019)
Figure Asia-Pacific Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2019)
Figure China Retinal Disorders Treatment Growth Rate (2017-2019)
Figure China Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Japan Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Korea Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Retinal Disorders Treatment Growth Rate (2017-2019)
Figure India Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Southeast Asia Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Retinal Disorders Treatment Growth Rate (2017-2019)
Figure South America Retinal Disorders Treatment Revenue and Growth Rate (2017-2019)
Figure South America Retinal Disorders Treatment by Countries (2017-2019)
Figure South America Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Brazil Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Argentina Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Columbia Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Rest of South America Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Middle East and Africa Retinal Disorders Treatment Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Retinal Disorders Treatment by Countries (2017-2019)
Figure Middle East and Africa Retinal Disorders Treatment Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Saudi Arabia Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Retinal Disorders Treatment Growth Rate (2017-2019)
Figure United Arab Emirates Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Egypt Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Nigeria Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Retinal Disorders Treatment Growth Rate (2017-2019)
Figure South Africa Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Turkey Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Retinal Disorders Treatment Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2017-2019)
Table Santen Pharmaceutical Co. Ltd. Retinal Disorders Treatment Financial Overview
Table REGENERON Retinal Disorders Treatment Financial Overview
Table Graybug Vision Inc. Retinal Disorders Treatment Financial Overview
Table Shire (Takeda Pharmaceuticals) Retinal Disorders Treatment Financial Overview
Table Bayer AG Retinal Disorders Treatment Financial Overview
Table Genentech Inc. Retinal Disorders Treatment Financial Overview
Table Acucela Inc. Retinal Disorders Treatment Financial Overview
Table Pfizer Inc. Retinal Disorders Treatment Financial Overview
Figure Global Retinal Disorders Treatment Revenue (Millions USD) and Growth Rate (2019-2027)
Table Retinal Disorders Treatment Market Forecast by Regions (2019-2027)
Figure North America Retinal Disorders Treatment Market Forecast (2019-2027)
Figure United States Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Canada Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Mexico Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Europe Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Germany Retinal Disorders Treatment Market Forecast (2019-2027)
Figure France Retinal Disorders Treatment Market Forecast (2019-2027)
Figure UK Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Russia Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Italy Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Rest of Europe Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Asia-Pacific Retinal Disorders Treatment Market Forecast (2019-2027)
Figure China Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Japan Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Korea Retinal Disorders Treatment Market Forecast (2019-2027)
Figure India Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Southeast Asia Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Retinal Disorders Treatment Market Forecast (2019-2027)
Figure South America Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Brazil Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Argentina Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Columbia Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Rest of South America Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Middle East and Africa Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Saudi Arabia Retinal Disorders Treatment Market Forecast (2019-2027)
Figure United Arab Emirates Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Egypt Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Nigeria Retinal Disorders Treatment Market Forecast (2019-2027)
Figure South Africa Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Turkey Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Retinal Disorders Treatment Market Forecast (2019-2027)
Figure Global Retinal Disorders Treatment Forecast by Type (2019-2027)
Figure Global Retinal Disorders Treatment Market Share Forecast by Type (2019-2027)
Figure Global Retinal Disorders Treatment Forecast by Type (2019-2027)
Figure Global Retinal Disorders Treatment Forecast by Applications (2019-2027)
Figure Global Retinal Disorders Treatment Market Share Forecast by Applications (2019-2027)
Figure Global Retinal Disorders Treatment Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|